Identification of immune activation-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma

Identification of immune activation-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma

BackgroundLung adenocarcinoma (LUAD) is a major subtype of non-small cell lung cancer (NSCLC) with a highly heterogeneous tumor microenvironment. Immune checkpoint inhibitors (ICIs) are more effective in tumors with a pre-activated immune status. However, the potential of the immune activation-assoc...

Full description

Bibliographic Details
Main Authors: Weibiao Zeng, Jin Wang, Jian Yang, Zhike Chen, Yuan Cui, Qifan Li, Gaomeng Luo, Hao Ding, Sheng Ju, Baisong Li, Jun Chen, Yufeng Xie, Xin Tong, Mi Liu, Jun Zhao
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-07-01
Series:Frontiers in Immunology
Subjects:
lung adenocarcinoma
immune activation
immune infiltration
immunotherapy efficacy
prognosis
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1217590/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1217590/full

Similar Items